Symbiome is a direct-to-consumer skin-care brand preparing to launch product lines that aim to shift the skin’s microbiome back to an "ancestral" state. The initial launch on Oct. 7 will include seven products (a cleanser called The Renewal, a moisturizer called The One, and face oils), with another slate of launches planned for Nov. 3, including holiday offerings. The company uses a science-driven approach led by founder and chief scientific officer Larry Weiss and CEO Vicki Levine, supported by a team of microbiologists; formulations use 10 ingredients per product or fewer and employ fermentation to unlock nutrients. Ingredients are primarily sourced from the Amazon/Brazil via a mix of plantation farming and limited wild crafting, with attention to sustainable and fair-trade practices. Symbiome says its formulations seek to deliver the benefits of microbes (for example replicating what microbes would make) without attempting direct re-engraftment. The brand will sell products via its website and industry sources projected it could reach $100 million in sales by 2025. The company intends to use new funding to continue its scientific work, build products, and grow community.

Total raised

$15M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2020